Atlas Trials

InSilico Medicine Hong Kong Limited

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch InSilico Medicine Hong Kong Limited

RecordFirmDate
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors (NCT06724042)InSilico Medicine Hong Kong Limited2026-12-30
Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT07687459)InSilico Medicine Hong Kong Limited2026-08-30
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) (NCT07265570)InSilico Medicine Hong Kong Limited2025-12-10
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors (NCT06414460)InSilico Medicine Hong Kong Limited2025-04-25
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors (NCT06566079)InSilico Medicine Hong Kong Limited2024-12-27
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (NCT05975983)InSilico Medicine Hong Kong Limited2024-02-08
Study Evaluating ISM5411 Administered Orally to Healthy Volunteers (NCT06012578)InSilico Medicine Hong Kong Limited2023-11-08
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT05938920)InSilico Medicine Hong Kong Limited2023-06-19

Track InSilico Medicine Hong Kong Limited automatically

Every clearance here is in the API, with alerts when new ones post.